{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:36:00Z","timestamp":1792992960925,"version":"4.5.0"},"reference-count":22,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.25122\/jml-2026-0074","type":"journal-article","created":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:05:41Z","timestamp":1792991141000},"page":"627-635","source":"Crossref","is-referenced-by-count":0,"title":["Multipathogen antimicrobial resistance in a Romanian tertiary-care hospital: a retrospective antibiogram analysis, January\u2013July 2025"],"prefix":"10.25122","volume":"19","author":[{"given":"Cristiana Ana-Maria Olgu\u021ba","family":"Penea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Ovidius University of Constan\u021ba, Constan\u021ba, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Melinte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cre\u021bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberiu","family":"Holban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina Maria","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Maria","family":"V\u0103c\u0103roiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Simona","family":"Cambrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Medicine, Ovidius University of Constan\u021ba, Constan\u021ba, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Gheorghi\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Prof. Dr. Agrippa Ionescu Clinical Emergency Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"issue":"10325","key":"ref1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A","year":"2022","unstructured":"1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet, 2022;399(10325):629-655","journal-title":"Lancet"},{"key":"ref2","first-page":"72","article-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024","unstructured":"2. World Health Organization, WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance, Geneva:World Health Organization, 2024;72ISBN: 978924-009346-1"},{"key":"ref3","article-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2023","author":"European Centre for Disease Prevention and Control","year":"2024","unstructured":"3. European Centre for Disease Prevention and Control, Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2023, Stockholm:ECDC, 2024;"},{"key":"ref4","article-title":"Antimicrobial resistance threats in the United States, 2021-2022","author":"Centers for Disease Control and Prevention","year":"2025","unstructured":"4. Centers for Disease Control and Prevention, Antimicrobial resistance threats in the United States, 2021-2022, Atlanta (GA):CDC, 2025;"},{"issue":"10459","key":"ref5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"5. GBD 2021 Antimicrobial Resistance Collaborators, Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050, Lancet, 2024;404(10459):1199-1226","journal-title":"Lancet"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL","year":"2018","unstructured":"6. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis, Lancet Infect Dis, 2018;18(3):318-327","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Multi-Drug Resistant Organism Network Investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G","year":"2020","unstructured":"7. van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Multi-Drug Resistant Organism Network Investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study, Lancet Infect Dis, 2020;20(6):731-741Epub 2020 Mar 6. Erratum in: Lancet Infect Dis. 2020 Jun;20(6):e116 doi: 10.1016\/S1473-3099(20)30354-6","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"ref8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3201\/eid2007.121004","article-title":"Deaths attributable to carbapenem-resistant Enterobacteriaceae infections","volume":"20","author":"Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ","year":"2014","unstructured":"8. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ, Deaths attributable to carbapenem-resistant Enterobacteriaceae infections, Emerg Infect Dis, 2014;20(7):1170-5","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/antibiotics15060621","article-title":"Determinants of Carbapenem-Resistant Klebsiella pneumoniae Clinical Outcomes and Epidemiological Risk Factors in a Single-Center Cohort Dataset","volume":"15","author":"Penea CAO, Melinte V, Cambrea CS, Holban T, Radu AM, Vacaroiu CM","year":"2026","unstructured":"9. Penea CAO, Melinte V, Cambrea CS, Holban T, Radu AM, Vacaroiu CM, Determinants of Carbapenem-Resistant Klebsiella pneumoniae Clinical Outcomes and Epidemiological Risk Factors in a Single-Center Cohort Dataset, Antibiotics (Basel), 2026;15(6):621","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/antibiotics14080783","article-title":"Epidemiology of carbapenem-resistant Klebsiella pneumoniae co-producing MBL and OXA-48-like in a Romanian tertiary hospital: a call to action","volume":"14","author":"Melinte V, Radu MA, V\u0103c\u0103roiu MC, Mirzan L, Holban TS, Ileanu BV","year":"2025","unstructured":"10. Melinte V, Radu MA, V\u0103c\u0103roiu MC, Mirzan L, Holban TS, Ileanu BV, Epidemiology of carbapenem-resistant Klebsiella pneumoniae co-producing MBL and OXA-48-like in a Romanian tertiary hospital: a call to action, Antibiotics (Basel), 2025;14783","journal-title":"Antibiotics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"dlag079","DOI":"10.1093\/jacamr\/dlag079","article-title":"Emergence of ST383 carbapenem-resistant Klebsiella pneumoniae harbouring blaNDM-5 and blaOXA-48 carbapenemase genes in a Romanian tertiary-care hospital","volume":"8","author":"Gheorghi\u021b\u0103 V, Dobrin A, Melinte V, Radu MA, V\u0103c\u0103roiu MC, Talpo\u0219 IF","year":"2026","unstructured":"11. Gheorghi\u021b\u0103 V, Dobrin A, Melinte V, Radu MA, V\u0103c\u0103roiu MC, Talpo\u0219 IF, Emergence of ST383 carbapenem-resistant Klebsiella pneumoniae harbouring blaNDM-5 and blaOXA-48 carbapenemase genes in a Romanian tertiary-care hospital, JAC Antimicrob Resist, 2026;8dlag079","journal-title":"JAC Antimicrob Resist"},{"key":"ref12","article-title":"Breakpoint tables for interpretation of MICs and zone diameters, version 15.0. V\u00e4xj\u00f6: EUCAST","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2025","unstructured":"12. European Committee on Antimicrobial Susceptibility Testing (EUCAST), Breakpoint tables for interpretation of MICs and zone diameters, version 15.0. V\u00e4xj\u00f6: EUCAST, 2025;"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA","year":"2022","unstructured":"13. Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine), Clin Microbiol Infect, 2022;28(4):521-547","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections","author":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA","year":"2024","unstructured":"14. Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA, Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections, Clin Infect Dis, 2024;ciae403","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R","year":"2021","unstructured":"15. Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R, Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial, Lancet Infect Dis, 2021;21(2):226-240","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"ref16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.arcmed.2021.09.002","article-title":"Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions","volume":"52","author":"Bassetti M, Vena A, Giacobbe DR, Castaldo N","year":"2021","unstructured":"16. Bassetti M, Vena A, Giacobbe DR, Castaldo N, Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions, Arch Med Res, 2021;52(8):817-827","journal-title":"Arch Med Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016","volume":"6","author":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN","year":"2019","unstructured":"17. Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN, Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016, Open Forum Infect Dis, 2019;6(Suppl 1):S79-S94","journal-title":"Open Forum Infect Dis"},{"key":"ref18","first-page":"48","article-title":"WHO fungal priority pathogens list to guide research, development and public health action","author":"World Health Organization","year":"2022","unstructured":"18. World Health Organization, WHO fungal priority pathogens list to guide research, development and public health action, Geneva:World Health Organization, 2022;48ISBN: 978-92-4-006024-1"},{"issue":"10","key":"ref19","doi-asserted-by":"publisher","first-page":"e00777","DOI":"10.1128\/AAC.00777-17","article-title":"Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam","volume":"61","author":"Mojica MF, Papp-Wallace KM, Taracila MA, Barnes MD, Rutter JD, Jacobs MR","year":"2017","unstructured":"19. Mojica MF, Papp-Wallace KM, Taracila MA, Barnes MD, Rutter JD, Jacobs MR, Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam, Antimicrob Agents Chemother, 2017;61(10):e00777-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav D, Giske CG, Gr\u0101matniece A, Abodakpi H, Tam VH, Leibovici L","year":"2021","unstructured":"20. Yahav D, Giske CG, Gr\u0101matniece A, Abodakpi H, Tam VH, Leibovici L, New \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations, Clin Microbiol Rev, 2021;34(1):e00115-20","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"ref21","doi-asserted-by":"publisher","first-page":"107113","DOI":"10.1016\/j.ijantimicag.2024.107113","article-title":"Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022)","volume":"63","author":"Sader HS, Carvalhaes CG, Kimbrough JH, Mendes RE, Castanheira M","year":"2024","unstructured":"21. Sader HS, Carvalhaes CG, Kimbrough JH, Mendes RE, Castanheira M, Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022), Int J Antimicrob Agents, 2024;63(4):107113","journal-title":"Int J Antimicrob Agents"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/antibiotics13060550","article-title":"Synergistic combination of aztreonam and ceftazidime-avibactam: a promising defense strategy against OXA-48 + NDM Klebsiella pneumoniae in Romania","volume":"13","author":"Cismaru IM, V\u0103c\u0103roiu MC, Soium E, Holban T, Radu AM, Melinte V","year":"2024","unstructured":"22. Cismaru IM, V\u0103c\u0103roiu MC, Soium E, Holban T, Radu AM, Melinte V, Synergistic combination of aztreonam and ceftazidime-avibactam: a promising defense strategy against OXA-48 + NDM Klebsiella pneumoniae in Romania, Antibiotics (Basel), 2024;13550","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-8-2026\/original-article-issue-8-2026\/multipathogen-antimicrobial-resistance-in-a-romanian-tertiary-care-hospital-a-retrospective-antibiogram-analysis-january-july-2025\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:05:43Z","timestamp":1792991143000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-8-2026\/original-article-issue-8-2026\/multipathogen-antimicrobial-resistance-in-a-romanian-tertiary-care-hospital-a-retrospective-antibiogram-analysis-january-july-2025\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["JMedLife-19-627"],"URL":"https:\/\/doi.org\/10.25122\/jml-2026-0074","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}